99 related articles for article (PubMed ID: 26323669)
1. ADAM15 targets MMP9 activity to promote lung cancer cell invasion.
Dong DD; Zhou H; Li G
Oncol Rep; 2015 Nov; 34(5):2451-60. PubMed ID: 26323669
[TBL] [Abstract][Full Text] [Related]
2. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
3. PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer.
Liu H; Wu Y; Zhu S; Liang W; Wang Z; Wang Y; Lv T; Yao Y; Yuan D; Song Y
Cancer Lett; 2015 Apr; 359(2):218-25. PubMed ID: 25617799
[TBL] [Abstract][Full Text] [Related]
4. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
5. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction.
Najy AJ; Day KC; Day ML
Cancer Res; 2008 Feb; 68(4):1092-9. PubMed ID: 18281484
[TBL] [Abstract][Full Text] [Related]
6. Expression of ADAM15 in lung carcinomas.
Schütz A; Härtig W; Wobus M; Grosche J; Wittekind Ch; Aust G
Virchows Arch; 2005 Apr; 446(4):421-9. PubMed ID: 15756594
[TBL] [Abstract][Full Text] [Related]
7. ADAM15 suppresses cell motility by driving integrin alpha5beta1 cell surface expression via Erk inactivation.
Chen Q; Meng LH; Zhu CH; Lin LP; Lu H; Ding J
Int J Biochem Cell Biol; 2008; 40(10):2164-73. PubMed ID: 18387333
[TBL] [Abstract][Full Text] [Related]
8. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
9. CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway.
Lin F; Chengyao X; Qingchang L; Qianze D; Enhua W; Yan W
Mol Carcinog; 2015 Jun; 54 Suppl 1():E35-44. PubMed ID: 24664993
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3.
Zhao B; Han H; Chen J; Zhang Z; Li S; Fang F; Zheng Q; Ma Y; Zhang J; Wu N; Yang Y
Cancer Lett; 2014 Jan; 342(1):43-51. PubMed ID: 23981581
[TBL] [Abstract][Full Text] [Related]
11. Relationship between matrix metalloproteinase 2 and lung cancer progression.
Guo CB; Wang S; Deng C; Zhang DL; Wang FL; Jin XQ
Mol Diagn Ther; 2007; 11(3):183-92. PubMed ID: 17570740
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
[TBL] [Abstract][Full Text] [Related]
13. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
15. GABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.
Liu L; Yang C; Shen J; Huang L; Lin W; Tang H; Liang W; Shao W; Zhang H; He J
Oncotarget; 2016 May; 7(22):32341-50. PubMed ID: 27081042
[TBL] [Abstract][Full Text] [Related]
16. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML
PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657
[TBL] [Abstract][Full Text] [Related]
17. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
20. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
